IndraLab

Statements


USP1 inhibits PC. 5 / 5
| 5

reach
"Collectively, we showed that USP1 interacts with KDM4A and promotes its deubiquitination, ultimately leading to KDM4A stabilization, and inhibition of USP1 promotes the response of PC cells to therapeutic agent enzalutamide."

reach
"These results reveal that targeting USP1 promotes PC cell response to therapeutic agent enzalutamide."

reach
"Notably, upregulation of KDM4A expression with high USP1 expression was observed in most prostate tumors and inhibition of USP1 promotes PC cells response to therapeutic agent enzalutamide."

reach
"In future, we will test whether inhibition of USP1 in enzalutamide resistant cells could promote the PC cell response to enzalutamide."

reach
"Furthermore, we found that USP1 knockdown reduced tumorigenesis and promoted PC cell response to therapeutic agent enzalutamide in a KDM4A dependent manner."